Continuous Glucose Monitoring Devices Market size was valued at USD 5365 million in 2021 and is expected to reach USD 25869 million by 2028, at a CAGR of 25.2% during the forecast period 2022-2028. Continuous glucose monitoring (CGM) is the novel technology to measure blood glucose in real-time throughout the day and night. Glucose sensors are placed under the skin in order to measure glucose levels in the blood. The transmitters are sending radiofrequency signals to a monitoring and display device. Adoption of advanced technologies to monitor the glucose levels able to create demand for Continuous Glucose Monitoring Devices Market. Global Continuous glucose monitoring devices market is expected to gain traction due to an increased global prevalence of diabetes coupled with the adoption of technological advancements. According to WHO, approximately 108 million adults were living with diabetes in 1980; it is reached to 422 million by 2014. The prevalence is doubled in adult population. Favourable reimbursement policies for global continuous glucose monitoring devices expected to boost the market over the forecast period. U.S. is expected to account for the predominant market share in North America, owing to the wide range of diabetes population in the country. Rise in the diabetes prevalence and inclined towards novel diagnostic devices is expected to drive the market over the forecast period. Mexico continuous glucose monitoring devices market is expected to accelerate due to increased prevalence of obesity and overweight. For instance, a prevalence of obesity is more than 33% in children and 70% in adults. The obesity is the prime factor, leads to diabetes. Mexico has the highest prevalence of diabetes among OECD countries. Lack funding and the dearth of advanced healthcare infrastructure in lower-income countries hamper the market. Most of the primary health-care practitioners unable to access basic technologies to manage diabetes.